1072-68-0 Usage
Description
1,4-Dimethylpyrazole, a chemical compound with the molecular formula C6H8N2, is a colorless solid that exhibits solubility in polar solvents. It is recognized for its diverse industrial applications and potential pharmaceutical uses, while also being noted for its low toxicity and minimal environmental and health risks when used with proper safety measures.
Uses
Used in Chemical Industry:
1,4-Dimethylpyrazole is used as a corrosion inhibitor for its ability to protect materials from degradation in corrosive environments, thereby extending their service life and reducing maintenance costs.
Used in Polymer Industry:
1,4-Dimethylpyrazole serves as a stabilizer for polymers, enhancing their resistance to degradation from environmental factors such as heat, light, and oxygen, which in turn improves the polymers' longevity and performance.
Used in Pharmaceutical Industry:
1,4-Dimethylpyrazole is used as a reagent in organic synthesis, contributing to the development of new pharmaceutical compounds and facilitating the synthesis of complex organic molecules.
Used in Research and Development:
1,4-Dimethylpyrazole is utilized in the investigation of its potential as a pharmaceutical agent, particularly as an inhibitor of cytochrome P450 enzymes, which are involved in the metabolism of various drugs and other substances in the body. This application could lead to advancements in drug interactions and efficacy studies.
Check Digit Verification of cas no
The CAS Registry Mumber 1072-68-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,7 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1072-68:
(6*1)+(5*0)+(4*7)+(3*2)+(2*6)+(1*8)=60
60 % 10 = 0
So 1072-68-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H8N2/c1-5-3-6-7(2)4-5/h3-4H,1-2H3
1072-68-0Relevant articles and documents
NEW CRTH2 ANTAGONISTS
-
Page/Page column 142-143, (2013/03/26)
The present invention relates to compounds of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by CRTh2 antagonist activity.
INHIBITORS OF AKT ACTIVITY
-
Page/Page column 90, (2008/12/08)
-
BICYCLIC COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
-
Page/Page column 59, (2010/10/20)
The present invention provides bicyclic beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer’s disease.